²©Ô´¹ú¼Ê

Ͷ×ÊÕß¹ØÏµ

INVESTOR RELATIONS

Ò½ÁÆÆ÷еÊг¡¸Å¿ö£ºÌìÏÂÓëÖйú


Ëæ×ž­¼ÃµÄÉú³¤¡¢Éú³ÝµÄÔöÌí¡¢Éç»áÀÏÁ仯ˮƽµÄÌá¸ß £¬ÒÔ¼°ÈËÃDZ£½¡ÒâʶµÄÒ»Ö±ÔöÇ¿ £¬È«ÇòÒ½ÁÆÆ÷еÊг¡ÐèÇóÒ»Á¬¿ìËÙÔöÌí £¬Ò½ÁÆÆ÷еÐÐÒµÊǵ±½ñÌìÏÂÉú³¤×î¿ìµÄÐÐÒµÖ®Ò» ¡£2017Äê £¬È«ÇòÒ½ÁÆÆ÷еÊг¡¹æÄ£Õ¹ÍûΪ4030ÒÚÃÀ½ð £¬µ½2022Äê £¬È«ÇòÒ½ÁÆÆ÷еÊг¡¹æÄ£½«µÖ´ï5220ÒÚÃÀ½ð £¬2016-2022ÄêCAGRÄ껯ÔöÌíÂÊΪ5.1% ¡£

 

ÓëÒ©ÎïÊг¡Ïà±È £¬2017ÄêÈ«Çò´¦·½Ò©Êг¡¹æÄ£7770ÒÚÃÀ½ð £¬µ½2022Äê £¬½«µÖ´ï1.043ÍòÒÚÃÀ½ð £¬CAGRÄ껯ÔöÌí5.2% ¡£2022Äê £¬Æ÷еÊг¡Ô¼Õ¼µ½È«ÇòÒ©ÎïÊг¡¹æÄ£µÄÒ»°ë £¬Á½¸öÊг¡µÄÔöËÙÏ൱ ¡£

 

È«ÇòÒ½ÁÆÆ÷еÐÐÒµ¼¯ÖÐ¶È½Ï¸ß £¬ÏÖÔÚÅÅÃûÌìÏÂǰ25λµÄÒ½ÁÆÆ÷е¹«Ë¾µÄÏúÊÛ¶îºÏ¼ÆÕ¼È«ÇòÒ½ÁÆÆ÷е×ÜÏúÊÛ¶îµÄ60% £¬¶øÉ¢²¼ÔÚÌìϸ÷µØµÄÊýÍò¼ÒÒ½ÁÆÆ÷е¹«Ë¾µÄÏúÊÛ¶îºÏ¼ÆÖ»Õ¼40%µÄ·Ý¶î ¡£´Ó¸÷¸ö¹ú¼ÒºÍµØÇø¿´ £¬ÃÀ¹úÎȾÓÐÐÒµÁúͷְλ £¬ÆäÒ½ÁÆÆ÷еÐÐÒµÏúÊÛÊÕÈëÔÚÈ«ÇòÕ¼±È´ï38.8% £¬Æä´Î»®·ÖÊÇÎ÷Å· £¬Õ¼±È30.80% £¬ÈÕ±¾Ô¼Õ¼9.4% £¬ÖйúÔ¼Õ¼3.8% £¬ÆäËü¹ú¼ÒºÍµØÇø¹²Õ¼17.2% ¡£

 

 

¡¡¡¡´ÓÊг¡¹æÄ£¾ÞϸÀ´¿´ £¬ÅÅÃûǰʮµÄÒÀ´ÎÊÇ£¨ÅÅÃû¶¼Æ¾Ö¤Ç°Ê®´óÏà¶Ô¼Æ£©

 

£¨1£©ÌåÍâÕï¶ÏInVitroDiagnostics

2016ÄêÊг¡¹æÄ£494ÒÚÃÀ½ð £¬2016-2022ÄêCAGR5.9% £¬¹æÄ£×î´ó¡¢ÔöËÙµÚ¶þ ¡£

£¨2£©ÐÄÔàCardiology

2016ÄêÊг¡¹æÄ£446ÒÚÃÀ½ð £¬2016-2022ÄêCAGR5.7% £¬¹æÄ£µÚ¶þ¡¢ÔöËÙ

£¨3£©Ó°ÏñÕï¶ÏDiagnosticImaging

2016ÄêÊг¡¹æÄ£392ÒÚÃÀ½ð £¬2016-2022ÄêCAGR3.4% £¬¹æÄ£µÚÈý¡¢ÔöËÙµÚÊ® ¡£

£¨4£©¹Ç¿ÆOrthopedics

2016ÄêÊг¡¹æÄ£350ÒÚÃÀ½ð £¬2016-2022ÄêCAGR4.0% £¬¹æÄ£µÚËÄ¡¢ÔöËٵھŠ¡£

£¨5£©ÑÛ¿ÆOphthalmics

2016ÄêÊг¡¹æÄ£260ÒÚÃÀ½ð £¬2016-2022ÄêCAGR5.3% £¬¹æÄ£µÚÎå¡¢ÔöËÙµÚÎå ¡£

£¨6£©Í¨Ë×¼°ÕûÐÎÊÖÊõGeneral&plasticsurgery

2016ÄêÊг¡¹æÄ£204ÒÚÃÀ½ð £¬2016-2022ÄêCAGR5.3% £¬¹æÄ£µÚÁù¡¢ÔöËÙµÚÎå ¡£

£¨7£©ÄÚ¾µ¼ì²éEndoscopy

2016ÄêÊг¡¹æÄ£178ÒÚÃÀ½ð £¬2016-2022ÄêCAGR6.4% £¬¹æÄ£µÚÆß¡¢ÔöËÙµÚÒ» ¡£

£¨8£©Ò©ÎïÔËÊäDrugDelivery

2016ÄêÊг¡¹æÄ£186ÒÚÃÀ½ð £¬2016-2022ÄêCAGR4.8% £¬¹æÄ£µÚ°Ë¡¢ÔöËÙµÚÆß ¡£

£¨9£©´´ÉËÕչ˻¤Ê¿WoundManagement

2016ÄêÊг¡¹æÄ£130ÒÚÃÀ½ð £¬2016-2022ÄêCAGR4.5% £¬¹æÄ£µÚ¾Å¡¢ÔöËÙµÚ°Ë ¡£

£¨10£©ÑÀ¿ÆDental

2016ÄêÊг¡¹æÄ£128ÒÚÃÀ½ð £¬2016-2022ÄêCAGR5.6% £¬¹æÄ£µÚÊ®¡¢ÔöËÙµÚËÄ ¡£

£¨11£©ÌÇÄò²¡Diabetes

2016ÄêÊг¡¹æÄ£110ÒÚ £¬2016-2022ÄêµÄCAGRΪ6.6% ¡£

£¨12£©Éö²¡Nephrology

2016ÄêÊг¡¹æÄ£110ÒÚ £¬2016-2022ÄêµÄCAGRΪ4.6% ¡£

£¨13£©Ò½Ôº×°±¸ºÍ¹©Ó¦GeneralHospital&HealthcareSupply

2016ÄêÊг¡¹æÄ£110ÒÚ £¬2016-2022ÄêµÄCAGRΪ2.5% ¡£

£¨14£©¶ú±ÇºíEar £¬Nose&Throat£¨ENT£©

2016ÄêÊг¡¹æÄ£80ÒÚ £¬2016-2022ÄêµÄCAGRΪ5.5% ¡£

£¨15£©Éñ¾­Neurology

2016ÄêÊг¡¹æÄ£74ÒÚ £¬2016-2022ÄêµÄCAGRΪ7.8% ¡£

 

ÌÇÄò²¡ºÍÉñ¾­ÁìÓòÔöÌíѸËÙ ¡£

 

2017Äê¶ÈÈ«Çò×î´óµÄ20¼ÒÒ½ÁÆÆ÷е¹«Ë¾ÅÅÐаñ

Medical Design &amp£» OUTSOURCINGÍøÕ¾Æ¾Ö¤ÆóÒµ2016ÄêÓªÊÕ×ܶÑз¢Ö§³ö¼°Ô±¹¤ÊýΪ²ÎÕÕ £¬ÇãÔþÁËÈ«ÇòÒ½ÁÆÆ÷еÐÐÒµ100Ç¿£¨Medtech’s 100 Largest Players£© ¡£ÃÀ¶ØÁ¦(90.6, -0.62, -0.68%)ÃûÁÐÊ×λ £¬ÄêÓªÊÕ297ÒÚÃÀÔª ¡£Ç¿Éú(130.75, -0.45, -0.34%)ºÍ·ÉÀûÆÖÃûÁеڶþºÍµÚÈýλ ¡£

 

Í̲¢ºÍÊÕ¹º¸Ä±äÁËÈ«ÇòÒ½ÁÆÆóÒµÊг¡µÄÃûÌà ¡£2015Äê £¬ÃÀ¶ØÁ¦ÊÕ¹ºÁË¿Â»Ý £¬½ÝÂõºÍ°îÃÀÁ½¼Ò¹«Ë¾ºÏ²¢£»µ¤ÄɺÕ(100.33, -1.38, -1.36%)ÔÚÊÕ¹ºÎ÷ÃÅ×ÓÒ½Áƹ«Ë¾ÁÙ´²Î¢ÉúÎïÓªÒµºó £¬ÖØÐ»ص½ÁËÉúÃü¿ÆÑ§ÐÐÒµ ¡£Ç¿Éú¹«Ë¾µÄÒ½ÁÆÆ÷еӪҵ½øÈë°ñµ¥µÚ¶þλ ¡£

 

ÒÔÏÂÊǰÙÇ¿°ñÖÐǰ20´óÒ½ÁÆÆ÷е¹«Ë¾£¨The 20 Largest Medical Device Companies In the World£© ¡£

¡¡¡¡

1¡¢ÃÀ¶ØÁ¦£¨Medtronic£© °®¶ûÀ¼   297.10ÒÚÃÀÔª

 

2¡¢Ç¿Éú£¨Johnson &amp£» Johnson£© ÃÀ¹ú 251.19ÒÚÃÀÔª

 

3¡¢·ÉÀûÆÖ£¨Royal Philips£© ºÉÀ¼ 192.90ÒÚÃÀÔª

 

4¡¢Í¨ÓÃµçÆø(12.77, -0.17, -1.31%)Ò½ÁÆ£¨GE Healthcare£© ÃÀ¹ú 182.90ÒÚÃÀÔª

 

5¡¢·ÑÉ­ÓÈ˹£¨Fresenius£© µÂ¹ú 179.10ÒÚÃÀÔª

 

6¡¢Î÷ÃÅ×Ó£¨Siemens£© µÂ¹ú 149.86ÒÚÃÀÔª

 

7¡¢¿µµÂÀÖ£¨Cardinal Health£© ÃÀ¹ú 135.00ÒÚÃÀÔª

 

8¡¢µ¤Äɺգ¨Danaher£© ÃÀ¹ú 131.90ÒÚÃÀÔª

 

9¡¢Ê·Èü¿Ë£¨Stryker£© ÃÀ¹ú 113.25ÒÚÃÀÔª

 

10¡¢°ÙÌØ£¨Baxter£© ÃÀ¹ú 101.63ÒÚÃÀÔª

 

11¡¢Å·Âó˹-ÂóÄÜ£¨Owens &amp£» Minor£© ÃÀ¹ú 97.23ÒÚÃÀÔª

 

12¡¢±ÌµÏ£¨Becton £¬ Dickinson£© ÃÀ¹ú 86.54ÒÚÃÀÔª

 

13¡¢²¨Ê¿¶Ù¿ÆÑ§£¨Boston Scientific£© ÃÀ¹ú 83.86ÒÚÃÀÔª

 

14¡¢ÒÀÊÓ·£¨Essilor£© ·¨¹ú 78.78ÒÚÃÀÔª

 

15¡¢½ÝÂõ°îÃÀ£¨Zimmer Biomet£© ÃÀ¹ú 76.84ÒÚÃÀÔª

 

16¡¢B£® Braun µÂ¹ú 71.65ÒÚÃÀÔª

 

17¡¢Åµ»ª(82.1, -1.20, -1.44%)£¨Novartis£© ÃÀ¹ú 58.12ÒÚÃÀÔª

 

18¡¢3M(201.96, -2.82, -1.38%) Co£® ÃÀ¹ú 55.27ÒÚÃÀÔª

 

19¡¢°ÂÁÖ°Í˹£¨Olympus Corp£®£© ÈÕ±¾ 52.94ÒÚÃÀÔª

 

20¡¢ÑÅÅà(64.03, -0.61, -0.94%)£¨Abbott£© ÃÀ¹ú 52.33ÒÚÃÀÔª

 

¡¡¡¡

ÖйúÒ½ÁÆÆ÷еÊг¡¸Å¿ö

ÎÒ¹úÒ½ÁÆÆ÷еÐÐÒµÔöÌíѸËÙ £¬Êг¡ÏúÊÛ¹æÄ£ÓÉ2006 ÄêµÄ 434 ÒÚÔªÔöÌíµ½ 2015 ÄêµÄ 3 £¬080 ÒÚÔª ¡£ÖйúÒ½ÁÆÆ÷еÐÐÒµÕý´¦ÓÚ¿ìËÙÉúÄ;à £¬Äê¾ùÔöËÙ15%-20% £¬Êг¡×ÜÈÝÁ¿½öΪͬÆÚÒ©Æ·Êг¡µÄ 14.8% ¡£

 

2016ÄêÖйúÒ½ÁÆÆ÷еÊг¡ÏúÊÛ¹æÄ£Ô¼Îª3700ÒÚÔª £¬±È2015Äê¶ÈµÄ3080ÒÚÔªÔöÌíÁË620ÒÚÔª £¬ÔöÌíÂÊԼΪ20.1% ¡£ÆäÖÐÒ½ÓÃÒ½ÁÆÆ÷еÊг¡Ô¼Îª2690ÒÚÔª £¬Ô¼Õ¼72.70%£»¼ÒÓÃÒ½ÁÆÆ÷еÊг¡Ê×´ÎÍ»ÆÆÇ§ÒÚÔª´ó¹Ø £¬Ô¼Îª1010ÒÚÔª £¬Ô¼Õ¼27.30% ¡£

 

¾ÝÖйúÒ½Ò©¹¤ÒµÐÅÏ¢ÖÐÐÄÕ¹Íû£º2019Ä꺣ÄÚÒ½ÁÆÆ÷еÊг¡¹æÄ£½«Áè¼Ý6000ÒÚÔª £¬ÈÔ½«¼á³Ö¿ìËÙÔöÌíÌ¬ÊÆ ¡£

 

2015Äê £¬Ò½ÁÆÆ÷е³ö¿Ú¶îÒѾ­µÖ´ï 384.89 ÒÚÃÀÔª £¬½ü 5 Ä긴ºÏÔöÌíÂʵִï 11.18% ¡£º£ÄÚÒ½ÁÆÆ÷еËÄ´ó°å¿é£ºÒ½ÁÆ×°±¸Êг¡¿Õ¼ä994ÒÚÔª¡¢¸ßÖµºÄ²ÄÊг¡¿Õ¼ä 359ÒÚÔª¡¢µÍÖµºÄ²ÄÊг¡¿Õ¼ä331ÒÚÔª¡¢IVD²úÆ·Êг¡¿Õ¼ä442ÒÚÔª ¡£ÏÖÔÚÎÒ¹úÒ½ÁÆÆ÷еÊг¡µÄ»ù±¾×é³ÉΪ£º¸ß¶Ë²úÆ·Õ¼±È25% £¬ÖеͶ˲úÆ·Õ¼±È75%£»¶ø¹ú¼ÊÒ½ÁÆÆ÷еÊг¡ÖÐµÄÆ½¾ùˮƽΪ£º¸ß¶Ë²úÆ·ËùÕ¼·Ý¶îÒ»Ñùƽ³£Îª55% £¬ÖеͶ˲úÆ·45% ¡£

 

ÎÒ¹úÒ½ÁÆÆ÷еÐÐÒµ¼¯ÖÐ¶ÈµÍ £¬Éú²úÆóÒµÉÏ16000¼Ò £¬¹æÄ£ÆÕ±é½ÏС ¡£ÂõÈðÒ½ÁÆ×÷Ϊº£ÄÚ×î´óµÄÒ½ÁÆÆ÷еÉú²úÉÌ £¬ 2016 ÄêÏúÊÛ¶îÁè¼Ý 90 ÒÚÔªÈËÃñ±Ò ¡£5000ÍòÔª²úÖµÒÔÉÏµÄÆóÒµ1800¼Ò £¬Ïà±ÈÍâÑóÆ÷еÉú²ú³§¼Òƽ¾ùÑз¢Í¶ÈëÕ¼±ÈµÄ 15% £¬º£ÄÚ³§ÉÌÑз¢Í¶ÈëÕ¼±È½öΪ3% ¡£Í¶Èëȱ·¦ÖÂʹ²úƷͬÖÊ»¯ÑÏÖØ ¡£¼à»¤¡¢ ³¬Éù¡¢×¢ÉäÆ÷¡¢Õæ¿Õ²ÉѪ¹ÜµÈÆ÷еµÄ×¢²áÖ¤¾ùÔÚ100ÕÅÒÔÉÏ ¡£¶àÄêÒÔÀ´ £¬ÊÖÒÕº¬ Á¿µÍ¡¢²î±ð»¯Ë®Æ½µÍµÄ¢ñÀà¡¢¢òÀàÆ÷еռÓк£ÄÚÕûÌåÒ½ÁÆÆ÷еµÄ¾ø´ó±ÈÀý ¡£

ȪԴ£ºÐÂÀ˲ƾ­

ÍøÕ¾µØÍ¼